Blood culture tests market Overview
Blood culture is a microbiological culture of blood. It is employed to detect infections that are spreading through the bloodstream (such as bacteremia, septicemia amongst others). This is possible because the bloodstream is usually a sterile environment. When a patient shows signs or symptoms of a systemic infection, results from a blood culture can verify that an infection is present, and they can identify the type (or types) of microorganism that is responsible for the infection. For example, blood tests can identify the causative organisms in severe pneumonia, puerperal fever, pelvic inflammatory disease, neonatal epiglottitis, sepsis, and fever of unknown origin (FUO). However, negative growths do not exclude infection.
The increase in the incidence of diseases such as blood stream infections, kidney disorders and other organ infections, aging population, high demand for rapid diagnostic tests are certain factors that drive the Blood culture tests market. The cost of highly automated blood testing, regulatory approval processes and lack of awareness on latest advancements however hinder the market growth.
Blood culture tests market Forecast Report (2018-2023)
Global Blood culture tests Market was worth $62.62 billion in 2018 and estimated to be growing at a CAGR of 2.6%, to reach $95.91 billion by 2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/blood-culture-tests-market-7802/
Blood culture tests market Segmentation
The global market is segmented on the basis Method, Product, Technology, Application and End User. On the basis of Method, it is segmented Automated and Manual. The conventional technique held the highest share in this market segment. The automated technique segment is expected to register the highest growth rate. On the basis of Product, it is segmented Consumables and Instrument. The consumables segment held the largest share in this market segment. The instruments segment is expected to witness the highest growth during the forecast period due to product advancements. On the basis of Technology, it is segmented culture-based, PCR, Microarray, and proteomic. The culture-based technology segment dominated the industry with the largest revenue share in this market segment. Molecular technology segment is anticipated to register the highest growth during the forecast period. On the basis of Application, it is segmented into Bacteremia and Fungemia. Bacterial infections segment dominated this segment of the market in terms of revenue in 2016. The bacterial infections segment is also anticipated to register the highest growth rate during the forecast period. On the basis of End User, it is segmented Hospital Laboratories and Reference Laboratories. The hospital laboratories accounted for the largest share in this market segment. Moreover, the hospital laboratories segment is expected to grow at the highest CAGR over the forecast period.
On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia Pacific, Middle East and Africa. Growing investments on R&D by manufactures for new product development in this region is expected to propel the growth of the Blood culture tests market. Also, growing investments in R&D by manufacturers for new product development in this region is expected to propel the growth of the industry.
The major companies dominating this market for its products and services are
- Yara International (Norway),
- Dickinson and Company,
- bioMérieux SA,
- Thermo Fisher Scientific Inc.,
- Cepheid, Inc.,
- Nanosphere Inc.,
- Beckman Coulter,
- Bruker Corporation, and
- T2 Biosystems.
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Sales Manager at Market Data Forecast